PKE Q1 2026 Earnings EPS of 015 Reported Amidst Quiet Quarter CBOE Q1 2026 Earnings EPS Surges Past Estimates on Strong Trading Activity FONR Q1 2025 Earnings Profitability Maintained Amid Limited Disclosure Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure THRY Q1 2026 Earnings Profitable Quarter Surges Past Expectations with 520 EPS Surprise CVBF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment